Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-25-000034
Filing Date
2025-05-01
Accepted
2025-05-01 16:02:14
Documents
90
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20250331.htm   iXBRL 10-Q 1177574
2 EX-31.1 exhibit3113312025.htm EX-31.1 9144
3 EX-31.2 exhibit3123312025.htm EX-31.2 9089
4 EX-32.1 exhibit3213312025.htm EX-32.1 8219
10 mrna-20250331_g1.jpg GRAPHIC 63925
11 mrna-20250331_g2.jpg GRAPHIC 335475
  Complete submission text file 0001682852-25-000034.txt   8852819

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20250331.xsd EX-101.SCH 54317
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20250331_cal.xml EX-101.CAL 110975
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20250331_def.xml EX-101.DEF 202336
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20250331_lab.xml EX-101.LAB 652703
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20250331_pre.xml EX-101.PRE 465854
93 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20250331_htm.xml XML 1369739
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 25902874
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)